GreenMark Biomedical, Inc. operates as a healthcare company. It develops technologies that involve small biopolymer particles produced from food grade starch. The firm?s diagnostic product is used by dental professionals as part of the routine dental exam, assess, and monitor non-invasive treatment of dental caries. The company was founded by Steven Bloembergen in March 2016 and is headquartered in East Lansing, MI.

Les Produits Chimiques Delmar, Inc. manufactures and markets active pharmaceutical ingredients. Its manufacturing capabilities include lab scale, pilot plant, and multi-ton production. The firm's services include process development and validation, analytical method development, stability studies according to ICH guidelines, custom synthesis from grams to multi-tons, peptide synthesis, technology transfer, complete regulatory documentation including DMF submissions, and patent applications. The company was founded in 1941 and is headquartered in LaSalle, Canada.

Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug; BMS753493, a folate-targeted anti-cancer therapy drug; EC0434 to target folate receptor positive tumors; and EC0305, an anti-cancer therapy drug. It also offers EC0286, a folate-targeted small molecule for the treatment of inflammatory diseases; and EC20, a folate-targeted radiopharmaceutical imaging agent to identify folate-receptor positive cancers. The company was founded in 1996 and is based in West Lafayette, Indiana.

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. Its products include fluorescent label protein, immune-checkpoint protein, and cytokine. The company was founded on July 22, 2010 and is headquartered in Beijing, China.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Alcon Research Ltd., a subsidiary of Nestl�� SA, is a company headquartered in Huntington, WV, that manufactures optical goods.

Hangzhou Dixiang Industrial Co., Ltd., established on 2015-01-08, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Biochemical product technology research and development;Research and development of bio-based materials technology;Research and development of bio-based material polymerization technology;Smart Home Gateway Manufacturing;Artificial intelligence application software development;software development;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of bio-based materials;Sales of Class I Medical Devices;IoT Device Sales;business management;Corporate Headquarters Management;Holding Company Services;Technology Import and Export;Import and export;Industrial Investment(Not approved by financial and other regulatory authorities,Not engage in financing deposits with the public,financing guarantee,Financial services such as wealth management on behalf of customers)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Ruilai Biotechnology Jiangsu Co., Ltd., established on 2010-12-24, The scope of business includes engaging in biomedicine,Biological product,R&D of medical devices,technical consulting,technology transfer,Technical extension services;Production of Class II Medical Devices(6840Clinical Laboratory Analytical Instruments,In vitro diagnostic reagents);one type,Wholesale of Class II and Class III medical devices;engaged in chemical products,Chemical raw materials(Free of Hazardous Chemicals),experiment equipment,plastic products,Glass product,Mechanical equipment and accessories,Electronic products and components,hardware products,electrical tools,Computer software and auxiliary equipment,Computer and Consumables,Packaging Materials,paper products,metallic material,Wholesale and retail of molds and mold accessories.Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).Production of Class III Medical Devices;software development;software sales;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;General merchandise sales;(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Puguang Bio is a developer of in vitro medical diagnostic systems. They create new biochemical sensors by focusing on the gold standard of modern testing technology and satisfying the needs of diverse markets based on customer requirements. It offers technical services to the public and has an all-around arrangement for the four sectors of drug testing, food testing, animal husbandry monitoring, and environmental monitoring.

Shenzhen Weigong Biotechnology Co., Ltd., established on 2017-06-19, Business scope includes general business items:engaged in biotechnology,Medical equipment and related accessories(including in vitro diagnostic reagents),Medical Device Software,Technology development of scientific research instruments,technology transfer,technical consulting,Technical Services;engaged in biotechnology,Medical equipment and related accessories(including in vitro diagnostic reagents),Medical Device Software,Operation and import and export of scientific research instruments;engaged in biological raw materials,one type,Class II medical devices and related accessories(including in vitro diagnostic reagents),Medical Device Software,Operation and service of scientific research instrument products.(Involves supporting license management,Commodities managed by special regulations shall be handled in accordance with relevant state regulations).,The licensing program is:engaged in biological raw materials,one type,Class II medical devices and related accessories(including in vitro diagnostic reagents),Medical Device Software,Production of scientific research instruments.

Tianjin Quanhecheng Technology Co., Ltd., established on 2010-10-27, Business scope includes general items:Biochemical product technology research and development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);R&D of industrial enzyme preparations;Fermentation process optimization technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Natural science research and experimental development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Sales of Class I Medical Devices;Business Management Consulting;Technology Import and Export;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Inspection and testing service;Drug Wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Established in August 2009, Hangzhou Huadsen Biotechnology Co., Ltd. is a key support enterprise of Hangzhou High-tech Enterprise and Hangzhou Science and Technology Startup Enterprise Cultivation Project (“The Eagle Project”). In 2016, it was recognized as a high-growth “Gazelle Enterprise” in Hangzhou High-tech Zone.

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.

BioLynx is a patented recombinant monoclonal antibody technology. Their services include antigen preparation, animal immunization, PBMC collection, B+ cell isolation, B+ cell culture, antibody validation, transfection, IgG expression, IgG DNA cloning, and immunoassays.

Shenzhen Boya Perception Pharmaceutical Co., Ltd., established on 2019-06-04, Business scope includes general business items:biopharmaceuticals,Research and Development of Biomaterials,technical consulting,technology transfer,Technical Services;Research and development of genetic testing technology and technical services;Provide management program services for medical institutions;sales of cosmetics.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:

Jiangxi Saiji Biotechnology Co., Ltd., established on 2017-05-02, The scope of business includes the production of medical devices,manufacture,Sales,technical consulting,Technical Services,technology development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)